Liver-Targeted Anti-HBV Single-Stranded Oligonucleotides with Locked Nucleic Acid Potently Reduce HBV Gene Expression In Vivo

Chronic hepatitis B infection (CHB) is an area of high unmet medical need. Current standard-of-care therapies only rarely lead to a functional cure, defined as durable hepatitis B surface antigen (HBsAg) loss following treatment. The goal for next generation CHB therapies is to achieve a higher rate...

Full description

Bibliographic Details
Main Authors:	Hassan Javanbakht, Henrik Mueller, Johanna Walther, Xue Zhou, Anaïs Lopez, Thushara Pattupara, Julie Blaising, Lykke Pedersen, Nanna Albæk, Malene Jackerott, Tianlai Shi, Corinne Ploix, Wouter Driessen, Robert Persson, Jacob Ravn, John A.T. Young, Søren Ottosen
Format:	Article
Language:	English
Published:	Elsevier 2018-06-01
Series:	Molecular Therapy: Nucleic Acids
Subjects:	HBV HBsAg viral gene expression AAV-HBV-infected mouse model locked nucleic acid antisense
Online Access:	http://www.sciencedirect.com/science/article/pii/S2162253118300192

Internet

http://www.sciencedirect.com/science/article/pii/S2162253118300192

Liver-Targeted Anti-HBV Single-Stranded Oligonucleotides with Locked Nucleic Acid Potently Reduce HBV Gene Expression In Vivo

Internet

Similar Items